-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Barinthus Biotherapeutics plc. quarterly/annual Deferred Income Tax Expense (Benefit) history and change rate from Q1 2021 to Q1 2025.
- Barinthus Biotherapeutics plc. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was -$22K, a 40.5% increase year-over-year.
- Barinthus Biotherapeutics plc. annual Deferred Income Tax Expense (Benefit) for 2024 was -$44K, a 98.6% increase from 2023.
- Barinthus Biotherapeutics plc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$3.08M, a 29.1% increase from 2022.
- Barinthus Biotherapeutics plc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$4.34M, a 3545% decline from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)